PON1 and metabolic syndrome: Numerous studies have shown a reduction in paraoxonase 1 activity in people with metabolic syndrome [30, 31].At present, more and more factors are being discussed that predispose early to the onset of atherosclerotic lesions and, consequently, to cardiovascular diseases.